# Bio-Techne (TECH) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/TECH
## Company Profile
- Ticker: TECH
- Exchange: NASDAQ
- Sector: Life Science Tools
- Location: United States
- Tags: Life Science Tools
## Stock Data
- Close: 72.23 USD
- Market cap: 7792426737.27 USD
- Last updated: 2026-08-12
## Business Overview
### Life-Science Research Tools
Bio-Techne supplies proteins, reagents, instruments, and diagnostic products used across biological research, drug development, manufacturing, and clinical testing. Its portfolio serves academic laboratories, biopharmaceutical companies, and diagnostic customers worldwide.
### R&D Systems
R&D Systems supports discovery, translational research, and bioprocessing with proteins, antibodies, assays, and related reagents. The portfolio includes GMP-grade proteins used in cell and gene therapy development and manufacturing.
### Bio-Techne Spatial
The Spatial business provides technologies for analyzing the location and expression of biological targets within tissue. These tools connect molecular signals with tissue architecture in oncology and translational medicine.
### Bio-Techne Diagnostics
The Diagnostics portfolio includes immunoassays, blood-chemistry and blood-gas quality controls, hematology controls, and custom reagents for diagnostic manufacturers and clinical laboratories.
### Pending Acquisition
Bio-Techne has agreed to be acquired by Merck KGaA, Darmstadt, Germany. Until the transaction closes, it continues operating through its three customer-focused brands and global research and diagnostic infrastructure.
## Why The Stock Is Moving

The latest monitored company update is “Bio-Techne Corrects Dividend Announcement.” The corresponding closing-price reaction is not yet available.

## Recent News
- 2026-08-13 10:30 EST — [Bio-Techne Corrects Dividend Announcement](https://biopharmsignal.com/news/TECH/bio-techne-corrects-dividend-announcement-3876976d) — Source: Bio-Techne
- 2026-08-12 10:30 EST — [Bio-Techne Releases Fourth Quarter Fiscal 2026 Results](https://biopharmsignal.com/news/TECH/bio-techne-releases-fourth-quarter-fiscal-2026-results-9446e3cd) — Source: Bio-Techne
- 2026-08-12 10:30 EST — [Bio-Techne Declares Dividend](https://biopharmsignal.com/news/TECH/bio-techne-declares-dividend-61c5d12a) — Source: Bio-Techne
- 2026-07-08 10:30 EST — [Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio](https://biopharmsignal.com/news/TECH/bio-techne-launches-expanded-r-d-systems-ai-engineered-designer-protein-portfoli-21b908e1) — Source: Bio-Techne
- 2026-06-25 10:10 EST — [Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets](https://biopharmsignal.com/news/TECH/merck-kgaa-darmstadt-germany-agrees-to-acquire-bio-techne-strengthening-leadersh-50e2ac1c) — Source: Bio-Techne